Research output per year
Research output per year
Fingerprint
Dive into the research topics where Yuya Koda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening
Mori, T., Kikuchi, T., Koh, M., Koda, Y., Yamazaki, R., Sakurai, M., Tomita, Y., Ozawa, Y., Kohashi, S., Abe, R., Saburi, M. & Kato, J., 2021 Jun, In: Bone Marrow Transplantation. 56, 6, p. 1266-1271 6 p.Research output: Contribution to journal › Article › peer-review
-
Erratum: Human herpesvirus 6 reactivation evaluated by digital polymerase chain reaction and its association with dynamics of CD134-positive T cells after allogeneic hematopoietic stem cell transplantation (J Infect Dis (2019) 220 (1001-1007) DOI: 10.1093/infdis/jiz237)
Nakayama, H., Yamazaki, R., Kato, J., Koda, Y., Sakurai, M., Abe, R., Watanuki, S., Sumiya, C., Shiroshita, K., Fujita, S., Yamaguchi, K., Okamoto, S. & Mori, T., 2021, In: Journal of Infectious Diseases. 221, 11, p. 1917 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies
Sakurai, M., Nannya, Y., Yamazaki, R., Yamaguchi, K., Koda, Y., Abe, R., Yokoyama, K., Ogawa, S. & Mori, T., 2021, (Accepted/In press) In: Annals of Hematology.Research output: Contribution to journal › Letter › peer-review
-
Impact of Specific Antibody Level on Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation: H. Nakayama et al
Nakayama, H., Yamazaki, R., Kato, J., Koda, Y., Sakurai, M. & Mori, T., 2021 Feb, In: Transplantation and Cellular Therapy. 27, 2, p. 174.e1-174.e5Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine
Kanto Study Group for Cell Therapy (KSGCT), 2021 Jan, In: International journal of hematology. 113, 1, p. 128-133 6 p.Research output: Contribution to journal › Article › peer-review